PCSK9 (Bococizumab Biosimilar) anticorps

N° du produit ABIN7490979

L’anticorps Humanized Monoclonal anti-PCSK9 (Bococizumab Biosimilar) a été validé pour FACS. Il convient pour détecter PCSK9 (Bococizumab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour PCSK9 (Bococizumab Biosimilar) anticorps (ABIN7490979)

Antigène: PCSK9 (Bococizumab Biosimilar)

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp PCSK9 (Bococizumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS)

Classe de qualité: Research Grade

Détail du produit anti-PCSK9 (Bococizumab Biosimilar) anticorps

Fonction: Anti-PCSK9 (Bococizumab biosimilar) mAb

Attributs du produit: PF-04950615, RN-316, RN316

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG2

Information d'application

Indications d'application: Flow Cyt  1:100

Commentaires:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur PCSK9 (Bococizumab Biosimilar)

Antigène: PCSK9 (Bococizumab Biosimilar)

Classe de substances: Biosimilar

Sujet: FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1, PC9

UniProt: Q8NBP7